Pro Share Advisors LLC Verastem, Inc. Transaction History

Pro Share Advisors LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$0.92 - $11.16 $1,180 - $14,318	1,283 Added 8.84%	15,797 $13,000
Q2 2022 Aug 01, 2022	SELL	$1.02 - $1.83 $37,393 - $67,087	-36,660 Reduced 71.64%	14,514 $17,000
Q1 2022 May 10, 2022	SELL	$1.06 - $2.1 $12,868 - $25,494	-12,140 Reduced 19.17%	51,174 $73,000
Q4 2021 Feb 08, 2022	BUY	$2.05 - $3.2 $5,350 - $8,352	2,610 Added 4.3%	63,314 $130,000
Q3 2021 Nov 12, 2021	SELL	$2.54 - $4.07 $37,863 - $60,671	-14,907 Reduced 19.72%	60,704 $187,000
Q2 2021 Aug 13, 2021	BUY	$2.57 - $4.85 $16,776 - $31,660	6,528 Added 9.45%	75,611 $308,000
Q1 2021 May 14, 2021	BUY	$1.9 - $2.82 $9,655 - $14,331	5,082 Added 7.94%	69,083 $171,000
Q4 2020 Feb 09, 2021	BUY	$1.15 - $2.4 $49,552 - $103,413	43,089 Added 206.05%	64,001 $136,000
Q3 2020 Nov 13, 2020	SELL	$1.11 - $1.68 $1,461 - $2,212	-1,317 Reduced 5.92%	20,912 $25,000
Q2 2020 Aug 03, 2020	BUY	$1.69 - $4.2 $37,567 - $93,361	22,229 New	22,229 $38,000
Q4 2019 Feb 12, 2020	SELL	$0.86 - $1.44 $17,260 - $28,900	-20,070 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$1.21 - $1.59 $10,612 - $13,945	-8,771 Reduced 30.41%	20,070 $24,000
Q2 2019 Aug 13, 2019	SELL	$1.25 - $3.14 $4,622 - $11,611	-3,698 Reduced 11.36%	28,841 $44,000
Q1 2019 May 15, 2019	BUY	$2.79 - $4.09 $786 - $1,153	282 Added 0.87%	32,539 $96,000
Q4 2018 Feb 14, 2019	BUY	$3.23 - $7.01 $104,190 - $226,121	32,257 New	32,257 $108,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.25B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.